Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever


Gül A., Ozdogan H., Erer B., Ugurlu S., Kasapcopur O. , Davis N., ...Daha Fazla

ARTHRITIS RESEARCH & THERAPY, cilt.17, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Introduction: This open-label pilot study aimed to investigate the efficacy of canakinumab in colchicine-resistant familial Mediterranean fever (FMF) patients.